
GLP-1 use in adults 65 and older with MASLD was linked to a 45% lower risk of death, and a 28% lower risk of hepatic decompensation, a new Houston Methodist Research Institute study shows.
Medicare’s GLP-1 Bridge program offers eligible Part D beneficiaries select GLP-1s for weight loss at $50/month, outside Part D, pending BALANCE model.
Medicare's GLP-1 Bridge program took effect July 1, 2026, allowing qualifying beneficiaries to buy certain weight-loss GLP-1 medications for $50 a month. Kylie Stengel, a principal at Avalere Health, answered several of the questions below about how the program works. Additional detail is drawn from CMS's own






